TNFRSF11A and breast cancer: Preclinical studies support RANK signaling as a therapeutic target in BC; it regulates mammary tumor initiation mediating the proliferative response to progesterone and the expansion of mammary stem cells and progenitors (Gonzalez‐Suarez et al, 2010; Joshi et al, 2010; Schramek et al, 2010).